Search This Blog

Friday, January 10, 2020

Elanco guides up to $3.1B in 2020 revenue

Elanco Animal Health (NYSE:ELANannounces 2020 guidance:
Revenue: $3.05B – 3.11B; EPS: $0.04 – 0.16; non-GAAP EPS: $1.09 – 1.16.
2019 results should be consistent with November guidance.
China regulators have signed off on the Bayer AG animal health merger.
Management will host a conference call today at 8:00 am ET to discuss its 2020 outlook.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.